Ident. | Authors (with country if any) | Title |
---|
000422 (2013) |
Emilie Secret [France] ; Kevin Smith [Australie] ; Valentina Dubljevic [Australie] ; Eli Moore [Australie] ; Peter Macardle [Australie] ; Bahman Delalat [Australie] ; Mary-Louise Rogers [Australie] ; Terrance G. Johns [Australie] ; Jean-Olivier Durand [France] ; Frédérique Cunin [France, Australie] ; Nicolas H. Voelcker [Australie] | Antibody‐Functionalized Porous Silicon Nanoparticles for Vectorization of Hydrophobic Drugs |
000966 (2010) |
Christophe Le Tourneau [France, Niger] ; Albiruni R A. Razak [Canada] ; Christine Levy [France] ; Valentin Calugaru [France] ; Olivier Galatoire [France] ; Rémi Dendale [France] ; Laurence Desjardins [France] ; Hui K. Gan [Australie] | Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland |
000B07 (2010) |
G. G. Wu [République populaire de Chine] ; C. Kaplan [France] ; B. R. Curtis [États-Unis] ; H. A. Pearson [Australie] | Report on the 14th international society of blood transfusion platelet immunology workshop |
000B94 (2010) |
Emmanuelle Bazin [France] ; Annick Mourot [France] ; Andrew R. Humpage [Australie] ; Valérie Fessard [France] | Genotoxicity of a freshwater cyanotoxin, cylindrospermopsin, in two human cell lines: Caco‐2 and HepaRG |
001419 (2007) |
Elias T. Zambidis [États-Unis] ; Lidia Sinka [France] ; Manuela Tavian [France] ; Venta Jokubaitis [Australie] ; Tea Soon Park [États-Unis] ; Paul Simmons [États-Unis] ; Bruno Péault [États-Unis] | Emergence of Human Angiohematopoietic Cells in Normal Development and from Cultured Embryonic Stem Cells |
001464 (2007) |
Michael Buchert [Australie, France] ; Carole Poon [Australie] ; James A. J. King [Australie] ; Thomas Baechi [Suisse] ; Giovanna D'Abaco [Australie] ; Frédéric Hollande [France] ; Christopher M. Hovens [Australie] | AF6/s‐afadin is a dual residency protein and localizes to a novel subnuclear compartment |
001534 (2006) |
Stephen S. Rich [États-Unis] ; Patrick Concannon [États-Unis] ; Henry Erlich [États-Unis] ; Cecile Julier [France] ; Grant Morahan [Australie] ; Jorn Nerup [Danemark] ; Flemming Pociot [Danemark] ; John A. Todd [Royaume-Uni] | The Type 1 Diabetes Genetics Consortium |
001543 (2006) |
Niels Schaft [Pays-Bas, Allemagne] ; Birgit Lankiewicz [Pays-Bas] ; Joost Drexhage [Pays-Bas] ; Cor Berrevoets [Pays-Bas] ; Denis J. Moss [Australie] ; Victor Levitsky [Suède] ; Marc Bonneville [France] ; Steven P. Lee [Royaume-Uni] ; Andrew J. Mcmichael [Royaume-Uni] ; Jan-Willem Gratama [Pays-Bas] ; Reinier L. H. Bolhuis [Pays-Bas] ; Ralph Willemsen [Pays-Bas] ; Reno Debets [Pays-Bas] | T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNγ production |
001572 (2006) |
J. L. Bernstein [États-Unis] ; S. Teraoka [États-Unis] ; M. C. Southey [Australie, France] ; M. A. Jenkins [Australie] ; I. L. Andrulis [Canada] ; J. A. Knight [Canada] ; E. M. John [États-Unis] ; R. Lapinski [États-Unis] ; A. L. Wolitzer [États-Unis] ; A. S. Whittemore [États-Unis] ; D. West [États-Unis] ; D. Seminara [États-Unis] ; E. R. Olson [États-Unis] ; A. B. Spurdle [Australie] ; G. Chenevix-Trench [Australie] ; G. G. Giles [Australie] ; J. L. Hopper [Australie] ; P. Concannon [États-Unis] | Population‐based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066–6T>G (IVS10–6T>G) from the Breast Cancer Family Registry |
001687 (2006) |
Nic Waddell [Australie] ; Jyoti Jonnalagadda [Australie] ; Anna Marsh [Australie] ; Scott Grist [Australie] ; Mark Jenkins [Australie] ; Karen Hobson [Australie] ; Malcolm Taylor [Royaume-Uni] ; Geoff J. Lindeman [Australie] ; Sean V. Tavtigian [France] ; Graeme Suthers [Australie] ; David Goldgar [États-Unis] ; Peter J. Oefner [Allemagne] ; Darrin Taylor [Australie] ; Sean Grimmond [Australie] ; Kum Kum Khanna [Australie] ; Georgia Chenevix-Trench [Australie] | Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling |
001794 (2005) |
M. Diez ; M. Guillotte ; C. Le Scanf ; H. Contamin ; P. David ; B. Cooke [Australie] ; O. Mercerau-Puijalon ; S. Bonnefoy | Revisiting Putative Functional Properties of the Plasmodium falciparum Pf155/RESA Protein Using Genetically Engineered Parasites |
001992 (2004) |
Richard J. N. Allcock [Australie] ; Lydia Windsor [Australie] ; Ivo G. Gut [France] ; Ramon Kucharzak [France, Allemagne] ; Laetitia Sobre [France] ; Doris Lechner [France] ; Jean-Guillaume Garnier [France] ; Svetlana Baltic [Australie] ; Frank T. Christiansen [Australie] ; Patricia Price [Australie] | High‐Density SNP genotyping defines 17 distinct haplotypes of the TNF block in the Caucasian population: Implications for haplotype tagging |
001B60 (2003) |
J. Lemaoult [France] ; M. Le Discorde [France] ; N. Rouas-Freiss [France] ; P. Moreau [France] ; C. Menier [France] ; J. Mccluskey [Australie] ; E. D. Carosella [France] | Biology and functions of human leukocyte antigen‐G in health and sickness |
001D55 (2001) |
Tounsia Ait Slimane [France] ; Christelle Lenoir [France] ; Valérie Bello [France] ; Jean-Louis Delaunay [France] ; James W. Goding [Australie] ; Serge Chwetzoff [France] ; Michèle Maurice [France] ; Jack A. M. Fransen [Pays-Bas] ; Germain Trugnan [France] | The Cytoplasmic/Transmembrane Domain of Dipeptidyl Peptidase IV, A Type II Glycoprotein, Contains an Apical Targeting Signal That Does Not Specifically Interact with Lipid Rafts |
001D95 (2001) |
F X Bosch [Espagne] ; T. Rohan [États-Unis] ; A. Schneider [Allemagne] ; I. Frazer [Australie] ; H. Pfister [Allemagne] ; X. Castellsagué [Espagne] ; S. De Sanjosé [Espagne] ; V. Moreno [Espagne] ; L M Puig-Tintore [Espagne] ; P G Smith [Royaume-Uni] ; N. Mu Oz [France] ; H. Zur Hausen [Allemagne] | Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference |
001E19 (2001) |
Sarah H. D Wilson [Australie] ; Angela M. Bailey [Australie] ; Craig R. Nourse [Australie] ; Marie-Geneviève Mattei [France] ; Jennifer A. Byrne [Australie] | Identification of MAL2, a Novel Member of the MAL Proteolipid Family, Though Interactions with TPD52-like Proteins in the Yeast Two-Hybrid System |
001E42 (2001) |
Teresa Mancilla [Mexique, Belgique] ; Lourdes Carrillo [Mexique] ; Luis S. Zamudio Rivera [Mexique] ; Carlos Camacho Camacho [Belgique, Mexique] ; Dick De Vos [Pays-Bas] ; Robert Kiss [Belgique] ; Francis Darro [France] ; Bernard Mahieu [Belgique] ; Edward R. T. Tiekink [Australie] ; Hubert Rahier [Belgique] ; Marcel Gielen [Belgique] ; Martine Kemmer [Belgique] ; Monique Biesemans [Belgique] ; Rudolph Willem [Belgique] | Di‐n‐butyltin(IV) derivatives of bis(carboxymethyl)benzylamines: synthesis, NMR and X‐ray structure characterization and in vitro antitumour properties |
001E68 (2001) |
Maria Kavallaris [Australie] ; Nicole M. Verrills [Australie] ; Bridget T. Hill [France] | Anticancer therapy with novel tubulin-interacting drugs |
001F62 (2000) |
Rosemary L. Balleine [Australie] ; Marlena Schoenberg Fejzo [États-Unis] ; Pavani Sathasivam [Australie] ; Paul Basset [France] ; Christine L. Clarke [Australie] ; Jennifer A. Byrne [Australie] | The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma |
001F76 (2000) |
Micheline Kirsch-Volders [Belgique] ; Toshio Sofuni [Japon] ; Marilyn Aardema [États-Unis] ; Silvio Albertini [Suisse] ; David Eastmond [États-Unis] ; Michael Fenech [Australie] ; Motoi Ishidate Jr. [Japon] ; Elisabeth Lorge [France] ; Hannu Norppa [Finlande] ; Jordi Surrallés [Espagne] ; Wilhelm Von Der Hude [Allemagne] ; Akihiro Wakata [Japon] | Report from the In Vitro Micronucleus Assay Working Group |
002014 (2000) |
Paul Jackson [Australie] ; Alain Puisieux [France] | Is the KAI1 Metastasis Suppressor Gene a Cellular Target of p53? A Review of Current Evidence |